NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mabtech AB

Mabtech AB

Private
SwedenHealthcare & Life Scienceshttps://www.mabtech.com/

Last Round

Buyout/LBO

Mar 1, 2024

Company Overview

Mabtech AB is a biotechnology company that develops, manufactures, and markets monoclonal antibodies, immunoassay kits, and analytical instruments for life science research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

ELISpotFluoroSpotmonoclonal antibodiesimmunoassay kitsimmune monitoringELISAsingle-cell analysislab reagentsautomated readercytokine secretionbiotech equipmentmultiplex immunoassaycustom antibody developmentlife science researchassay development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mabtech AB Comparables

Compare Mabtech AB with similar companies based on industry and business-model similarity.

Mabtech AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellular Technology Limited
92%
U-CyTech biosciences
83%
Bio-Techne Corporation
82%

Mabtech AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOMar 1, 2024
Buyout/LBODec 1, 2019

Key People

Founding team and executive leadership

MADHAVAN NAIR

Chief Executive Officer

Executive Team

Phill Keefe

Chief Executive Officer

Executive Team

Christian Smedman

Chief Technology Officer

Executive Team

Jonas Winberg

Group CFO

Executive Team

Mabtech AB Investors

Notable investors and investment history

Mabtech AB investors
InvestorRounds
Harmar ABBuyout/LBO
EQT ABBuyout/LBO
IK PartnersBuyout/LBO
Mérieux Equity PartnersBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2024

    EQT AB led the buyout round.

Mabtech AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mabtech AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mabtech AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersSweden
Employee Range129
Year Founded1986
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.